Cosmos & Physics
Verve gene editor lowers cholesterol in new study
A single infusion of Verve's experimental gene editor, VERVE-102, slashed patients' LDL cholesterol by 62% in a recent study, offering a potential one-time solution for a lifelong condition.
Dr. Evelyn Reed·May 25, 2026
